29 July 2010 08:27 [Source: ICIS news]
LONDON (ICIS)--Solvay's second quarter profits from its continuing chemicals and plastics operations improved markedly while the group reported a 32% fall in net income to $57m following the sale of its pharma business, it said on Thursday.
Recurring operating profits (REBIT - recurring earnings before interest and tax) for the continuing operations in the quarter were €183m compared with €63m in the second quarter of 2009 and €115m in the first quarter of 2010.
Chemicals REBIT were 11% higher at €80m while plastics earnings shot to €114m from just €8m in the prior year period although vinyls margins in Europe and the Mercosur region were under pressure.
Chemicals sales were up 12% at €762m and plastics sales up 50% at €1.09bn with a significant increase in sales volumes of speciality polymers, Solvay said.
($1 = €0.77)
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
|ICIS news FREE TRIAL|
|Get access to breaking chemical news as it happens.|
|ICIS Global Petrochemical Index (IPEX)|
|ICIS Global Petrochemical Index (IPEX). Download the free tabular data and a chart of the historical index|
Asian Chemical Connections